Post-approval studies (Phase 4)UnknownNCT00180128
What this trial is testing
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Who this might be right for
Leukemia, Promyelocytic, Acute
Technische Universität Dresden 80
Showing 20 of 0 results